| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Pseudoephedrine hydrochloride |
Is a |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine measurement |
Component |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Pseudoephedrine adverse reaction |
Causative agent (attribute) |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to pseudoephedrine (finding) |
Causative agent (attribute) |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Urine pseudoephedrine measurement (procedure) |
Component |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Pseudoephedrine 30mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Azatadine maleate+pseudoephedrine sulfate 1mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 4mg/5mL/60mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/15mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 2mg/5mL/30mg/5mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely carbinoxamine maleate 4 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fexofenadine hydrochloride+pseudoephedrine hydrochloride 60mg/120 mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Loratadine+pseudoephedrine sulfate 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 15mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Azatadine maleate + pseudoephedrine sulphate 1mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Cetirizine hydrochloride + pseudoephedrine 5mg/120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochlorid 8mg/2.5mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorphenamine maleate 4 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Fexofenadine hydrochloride + pseudoephedrine hydrochlorid 60mg/120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Loratadine 10 mg and pseudoephedrine sulfate 240 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methscopolamine nitrate + pseudoephedrine hydrochlorid 2.5mg/120mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine hydrochloride 120 mg and terfenadine 60 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely pseudoephedrine hydrochloride 60 milligram and triprolidine hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 30mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ibuprofen+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine compound product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Pseudoephedrine sulfate |
Is a |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Paracetamol 500 mg and pseudoephedrine hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing paracetamol and pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine 15mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing naproxen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Naproxen sodium 220mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorphenamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dexbrompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing codeine and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorphenamine- and hydrocodone- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing dexbrompheniramine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dextromethorphan and doxylamine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing dextromethorphan and diphenhydramine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Chlorphenamine- and codeine- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dextromethorphan and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Paracetamol- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Pseudoephedrine + guaifenesin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine maleate + pseudoephedrine + acetaminophen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorphenamine and ibuprofen and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Chlorpheniramine 2mg/ibuprofen 200mg/pseudoephedrine 30mg caplet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine 240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 1200mg m/r/pseudoephedrine 120mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 600mg m/r/pseudoephedrine 60mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing desloratadine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Desloratadine 5mg/pseudoephedrine 240mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dexbrompheniramine 6mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorphenamine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing diphenhydramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Naproxen 200mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Desloratadine 2.5mg/pseudoephedrine 120mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ibuprofen+pseudoephedrine 100mg/15mg oral 5mL suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing brompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing acrivastine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Pseudoephedrine- and triprolidine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ibuprofen- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing codeine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and dextromethorphan and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing chlorphenamine and paracetamol and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to pseudoephedrine (finding) |
Causative agent (attribute) |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ibuprofen 300 milligram and pseudoephedrine 45 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Ibuprofen 200 mg and pseudoephedrine 30 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely ibuprofen 200 milligram and pseudoephedrine 30 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing carbinoxamine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing fexofenadine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Pseudoephedrine hydrochloride |
Is modification of (attribute) |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Pseudoephedrine sulfate |
Is modification of (attribute) |
True |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Guaifenesin 1200mg /pseudoephedrine 120mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pseudoephedrine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]